The STEP-4 trial found that patients who switched from semaglutide 2.4 mg to placebo after 20 weeks regained approximately two-thirds of their prior weight loss over the next year, while those who stayed on 2.4 mg continued to lose (Rubino et al., JAMA 2021)
doi: 10.1016/j.jep.2015.12.004, 127
Are able to attend scheduled study visits and follow the study protocol Are comfortable with injectable treatments and regular health assessments During a screening visit, the study team will review your medical history, current medications, and lab results to confirm whether you meet all of the inclusion and exclusion criteria
72 Previous Study has shown that SAH can reduce the expression of DNA methyltransferase DNMT1 protein, lead to demethylation of the CpG islands in the NF-B gene promoter region, and increase NF-B expression, trigger the expression of pro-inflammatory senescence-associated secretory phenotype (SASP) factors, and thus induce cellular senescence in rat aortic smooth muscle cells
generic drug supply chain
Retrieved March 26, 2025, from Katzung BG, Masters SB, Trevor AJ